ACTRN12612000602820已完成3 期
Safety and efficacy of topical Silymarin (SM) cream in a randomized double-blind placebo controlled study for treatment of melasma patients.
D Tagreed Altaei0 个研究点目标入组 100 人开始时间: 2012年6月5日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 20 Years 至 70 Years（—）
- 性别
- All
入选标准
- •The inclusion criteria were adults with melasma without any topical, systemic, laser, and surgical treatment on face during the previous 3 months.
- •Each subject signed a written informed consent.
排除标准
- •The exclusion criteria were pregnant and nursing women, patients with history of hypersensitivity to some of the components of the formulas of the study, and coexistence of associate diseases and other pigmentation diseases, and concomitant use of other skin care products or systemic treatments.
研究者
相似试验
招募中
3 期
Evaluation of topical sylimarin formulation efficacy in prevention of radiotherapy induced skin reactions in breast cancer patientsIRCT2016110730760N1Vice chancellor for research, Mashhad University of Medical Sciences40
招募中
3 期
Evaluation of silymarin tablet efficacy in prevention of hepatotoxicity induced by doxorubicin containing chemotherapy regimen in patients with non-metastatic breast cancerIRCT20200408046990N6Mashhad University of Medical Sciences50
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140
招募中
2 期
The efficacy and safety of Silymarin in chemotherapy-induced peripheral neuropathy (CIPN)Chemotherapy induced peripheral neuropathy in confirmed diagnosed cancer patients..Serum neuropathyG61.1IRCT20201128049515N1Mazandaran University of Medical Sciences80
尚未招募
3 期
Effect of silymarin in inflammatory bowel diseaseK50-K52Inflammatory Bowel Disease.Noninfective inflammatory bowel diseaseIRCT20101107005123N3Mashhad University of Medical Sciences40